0
0

Substance-Related and Addictive Disorders

DOI: 10.1176/appi.books.9780890425596.190656

Sections

Excerpt

The substance-related disorders encompass 10 separate classes of drugs: alcohol; caffeine; cannabis; hallucinogens (with separate categories for phencyclidine [or similarly acting arylcyclohexylamines] and other hallucinogens); inhalants; opioids; sedatives, hypnotics, and anxiolytics; stimulants (amphetamine-type substances, cocaine, and other stimulants); tobacco; and other (or unknown) substances. These 10 classes are not fully distinct. All drugs that are taken in excess have in common direct activation of the brain reward system, which is involved in the reinforcement of behaviors and the production of memories. They produce such an intense activation of the reward system that normal activities may be neglected. Instead of achieving reward system activation through adaptive behaviors, drugs of abuse directly activate the reward pathways (Koob 2006). The pharmacological mechanisms by which each class of drugs produces reward are different, but the drugs typically activate the system and produce feelings of pleasure, often referred to as a “high.” Furthermore, individuals with lower levels of self-control, which may reflect impairments of brain inhibitory mechanisms, may be particularly predisposed to develop substance use disorders, suggesting that the roots of substance use disorders for some persons can be seen in behaviors long before the onset of actual substance use itself (Moffitt et al. 2011).

Your session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Anchor for Jump
Table 1 Diagnoses associated with substance class

References

Boyer EW: Management of opioid analgesic overdose. N Engl J Med 367(2):146–155, 2012
[PubMed]
 
Ahmadi J, Kampman K, Dackis C, et al: Cocaine withdrawal symptoms identify “Type B” cocaine-dependent patients. Am J Addict 17(1):60–64, 2008
[PubMed]
 
Ahmadi J, Kampman KM, Oslin DM, et al: Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment. Am J Addict 18(1):81–86, 2009
[PubMed]
 
McGregor C, Srisurapanont M, Jittiwutikarn J, et al: The nature, time course and severity of methamphetamine withdrawal. Addiction 100(9):1320–1329, 2005
[PubMed]
 
Licata SC, Rowlett JK: Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond. Pharmacol Biochem Behav 90(1):74–89, 2008
[PubMed]
 
Substance Abuse and Mental Health Services Administration: Results from the 2010 National Survey on Drug Use and Health: summary of national findings. NSDUH Series H-41, HHS Publ No (SMA) 11-4658. Rockville, MD, Substance Abuse and Mental Health Services Administration, 2011
 
Hasin DS, Fenton MC, Beseler C, et al: Analyses related to the development of DSM-5 criteria for substance use related disorders, 2: proposed DSM-5 criteria for alcohol, cannabis, cocaine and heroin disorders in 663 substance abuse patients. Drug Alcohol Depend 122(1–2):28–37, 2012
[PubMed]
 
Koob GF: Neurobiological substrates for the dark side of compulsivity in addiction. Neuropsychopharmacology 56(suppl 1):18–31, 2009
[PubMed]
 
Agrawal A, Pergadia ML, Lynskey MT: Is there evidence for symptoms of cannabis withdrawal in the national epidemiologic survey of alcohol and related conditions? Am J Addict 17(3):199–208, 2008
[PubMed]
 
Allsop DJ, Norberg MM, Copeland J, et al: The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress. Drug Alcohol Depend 119(1–2):123–129, 2011
[PubMed]
 
Budney AJ, Hughes JR: The cannabis withdrawal syndrome. Curr Opin Psychiatry 19(3):233–238, 2006
[PubMed]
 
Budney AJ, Hughes JR, Moore BA, Vandrey RA: Review of the validity and significance of the cannabis withdrawal syndrome. Am J Psychiatry 161(11):1967–1977, 2004
[PubMed]
 
Budney A, Moore BA, Vandrey R: Health consequences of marijuana use, in Handbook of the Medical Consequences of Alcohol and Drug Abuse. Edited by Brick J. Philadelphia, PA, Haworth Press/Taylor & Francis, 2008, pp 251–282
 
Chung T, Martin CS, Cornelius JR, Clark DB: Cannabis withdrawal predicts severity of cannabis involvement at 1-year follow-up among treated adolescents. Addiction 103(5):787–799, 2008
[PubMed]
 
Copersino ML, Boyd SJ, Tashkin DP, et al: Cannabis withdrawal among non-treatment-seeking adult cannabis users. Am J Addict 15(1):8–14, 2006
[PubMed]
 
Cornelius JR, Chung T, Martin C, et al: Cannabis withdrawal is common among treatment-seeking adolescents with cannabis dependence and major depression, and is associated with rapid relapse to dependence. Addict Behav 33(11):1500–1505, 2008
[PubMed]
 
Hasin DS, Keyes KM, Alderson D, et al: Cannabis withdrawal in the United States: results from NESARC. J Clin Psychiatry 69(9):1354–1363, 2008
[PubMed]
 
Levin KH, Copersino ML, Heishman SJ, et al: Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers. Drug Alcohol Depend 111(1–2):120–127, 2010
[PubMed]
 
Schuckit MA: Drug and Alcohol Abuse: A Clinical Guide to Diagnosis and Treatment, 6th Edition. New York, Springer, 2005, pp 192–209
 
Licata SC, Rowlett JK: Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond. Pharmacol Biochem Behav 90(1):74–89, 2008
[PubMed]
 
O’Brien CP: Benzodiazepine use, abuse and dependence. J Clin Psychiatry 66(suppl 2):28–33, 2005
[PubMed]
 
de Win MM, Jager G, Booij J, et al: Neurotoxic effects of ecstasy on the thalamus. Br J Psychiatry 193(4):289–296, 2008
[PubMed]
 
El-Mallakh RS, Halpern JH, Abraham HD: Substance abuse: hallucinogen- and MDMA-related disorders, in Psychiatry, 3rd Edition. Edited by Tasman A, Kay J, Lieberman JA, et al. London, Wiley, 2008, pp 1100–1126
 
Halpern JH: Hallucinogens: an update. Curr Psychiatry Rep 5(5):347–354, 2003
[PubMed]
 
Martin PR: Substance-related disorders, in Current Diagnosis and Treatment: Psychiatry, 2nd Edition. Edited by Ebert MH, Loosen PT, Nurcombe B, Leckman JF. New York, McGraw-Hill Medical, 2008, pp 230–260
 
Substance Abuse and Mental Health Services Administration: Results from the 2010 National Survey on Drug Use and Health: summary of national findings. NSDUH Series H-41, HHS Publ No (SMA) 11-4658. Rockville, MD, Substance Abuse and Mental Health Services Administration, 2011. Available at: http://www.samhsa.gov/data/NSDUH/2k10Results/Web/HTML/2k10Results.htm. Accessed March 20, 2012.
 
Baldridge EB, Bessen HA: Phencyclidine. Emerg Med Clin North Am 8(3):541–550, 1990
[PubMed]
 
Bey T, Patel A: Phencyclidine intoxicatiaon and adverse effects: a clinical and pharmacological review of an illicit drug. Cal J Emerg Med 8(1):9–14, 2007
[PubMed]
 
Johnston LD, O’Malley PM, Bachman JG, Schulenberger JE: Monitoring the Future National Results on Adolescent Drug Use: overview of key findings, 2011. Ann Arbor, Institute for Social Research, The University of Michigan, 2012
 
McCarron MM, Schulze BW, Thompson GA, et al: Acute phencyclidine intoxication: clinical patterns, complications, and treatment. Ann Emerg Med 10(6):290–297, 1981a
[PubMed]
 
McCarron MM, Schulze BW, Thompson GA, et al: Acute phencyclidine intoxication: incidence of clinical findings in 1,000 cases. Ann Emerg Med 10(5):237–242, 1981b
[PubMed]
 
Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality: National Survey on Drug Use and Health (NSDUH) series. 2009 and 2010. Available at: http://www.icpsr.umich.edu/icpsrweb/SAMHDA/series/64. Accessed September 20, 2012.
 
Langston JW, Palfreman J: The Case of the Frozen Addicts. New York, Pantheon, 1995
 
Marsolek MR, White NC, Litvitz TL: Inhalant abuse: monitoring trends by using poison control data, 1993–2008. Pediatrics 125(5):906–913, 2010
[PubMed]
 
Substance Abuse and Mental Health Services Administration: Results from the 2010 National Survey on Drug Use and Health: summary of national findings. NSDUH Series H-41, HHS Publ No (SMA) 11-4658.Rockville, MD, Substance Abuse and Mental Health Services Administration, 2011a
 
Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality: 2010 National Survey on Drug Use and Health: Table 1.45B Inhalant use in lifetime, past year, and past month among persons aged 12 to 17, by demographic characteristics: percentages, 2009 and 2010, and Table 1.46B Inhalant use in lifetime, past year, and past month among persons aged 18 to 25, by demographic characteristics: percentages, 2009 and 2010. Rockville, MD, Substance Abuse and Mental Health Services Administration, 2011b. Available at: http:oas.samhsa.gov/nsduh/2K10NSDUH/tabs/Sect1peTabs1to46.htm#tab1.45B and http:oas.samhsa.gov/nsduh/2K10NSDUH/tabs/Sect1peTabs1to46.htm#tab1.46B Accessed June 15, 2012.
 
DiFranza JR: Hooked from the first cigarette. Sci Am 298(5):82–87, 2008
[PubMed]
 
Hughes JR: Possible effects of smoke-free inpatient units on psychiatric diagnosis and treatment. J Clin Psychiatry 54(3):109–114, 1993
[PubMed]
 
Hughes JR: Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res 9(3):315–327, 2007
[PubMed]
 
Kroon L: Drug interactions with smoking. Am J Health Syst Pharm 64(18):1917–1921, 2007
[PubMed]
 
Pergadia ML, Heath AC, Martin NG, Madden PA: Genetic analyses of DSM-IV nicotine withdrawal in adult twins. Psychol Med 36(7):963–972, 2006
[PubMed]
 
Prochaska J, Delucchi K, Hall SM: A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. J Consult Clin Psychol 72(6):1144–1156, 2004
[PubMed]
 
SRNT Subcommittee on Biochemical Verification: Biochemical verification of tobacco use and cessation. Nicotine Tob Res 4(2):149–159, 2002
[PubMed]
 
Ziedonis D, Hitsman B, Beckham JC, et al: Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob Res 10(12):1691–1715, 2008
[PubMed]
 
Abraham HD: Visual phenomenology of the LSD flashback. Arch Gen Psychiatry 40(8):884–889, 1983
[PubMed]
 
Baggott MJ, Coyle JR, Erowid E, et al: Abnormal visual experiences in individuals with histories of hallucinogen use: a Web-based questionnaire. Drug Alcohol Depend 114(1):61–67, 2011
[PubMed]
 
El-Mallakh RS, Halpern JH, Abraham HD: Substance abuse: hallucinogen- and MDMA- related disorders, in Psychiatry, 3rd Edition. Edited by Tasman A, Kay J, Lieberman JA, et al. London, Wiley, 2008, pp 1100–1126
 
Halpern JH, Pope HGJr: Hallucinogen persisting perception disorder: what do we know after 50 years?Drug Alcohol Depend 69(2):109–119, 2003
[PubMed]
 
Hughes JR, Oliveto AH, Liguori A, et al: Endorsement of DSM-IV dependence criteria among caffeine users. Drug Alcohol Depend 52(2):99–107, 1998
[PubMed]
 
Juliano LM, Griffiths RR: A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology (Berl) 176(1):1–29, 2004
[PubMed]
 
Juliano LM, Griffiths RR: Caffeine-related disorders, in Kaplan and Sadock’s Comprehensive Textbook of Psychiatry, 9th Edition. Edited by Sadock BJ, Sadock VA, Ruiz P. Philadelphia, PA, Lippincott Williams & Wilkins, 2009, pp 1296–1308
 
Kendler KS, Myers J, O Gardner C: Caffeine intake, toxicity and dependence and lifetime risk for psychiatric and substance use disorders: an epidemiologic and co-twin control analysis. Psychol Med 36(12):1717–1725, 2006
[PubMed]
 
Lai MW, Klein-Schwartz W, Rodgers GC, et al: 2005 Annual Report of the American Association of Poison Control Centers’ national poisoning and exposure database. Clin Toxicol 44(6–7):803–932, 2006
[PubMed]
 
McCarthy DM, Mycyk MB, DesLauriers CA: Hospitalization for caffeine abuse is associated with abuse of other pharmaceutical products. Am J Emerg Med 26(7):799–802, 2008
[PubMed]
 
Reissig CJ, Strain EC, Griffiths RR: Caffeinated energy drinks—a growing problem. Drug Alcohol Depend 99(1–3):1–10, 2009
[PubMed]
 
Walsh MJ, Marquardt KA, Albertson TE: Adverse effects from the ingestion of Redline energy drinks. Clin Toxicol 44:642, 2006
 
Griffiths RR, Bigelow GE, Liebson IA: Human coffee drinking: reinforcing and physical dependence producing effects of caffeine. J Pharmacol Exp Ther 239(2):416–425, 1986
[PubMed]
 
Hughes JR, Oliveto AH, Bickel WK, et al: Caffeine self-administration and withdrawal: incidence, individual differences and interrelationships. Drug Alcohol Depend 32(3):239–246, 1993
[PubMed]
 
Hughes JR, Oliveto AH, Liguori A, et al: Endorsement of DSM-IV dependence criteria among caffeine users. Drug Alcohol Depend 52(2):99–107, 1998
[PubMed]
 
James JE: Understanding Caffeine. Thousand Oaks, CA, Sage, 1997
 
Juliano LM, Griffiths RR: A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology (Berl) 176(1):1–29, 2004
[PubMed]
 
Juliano LM, Griffiths RR: Caffeine-related disorders, in Comprehensive Textbook of Psychiatry, 9th Edition. Edited by Sadock BJ, Sadock VA, Ruiz P. Philadelphia, PA, Lippincott Williams & Wilkins, 2009, pp 1296–1308
 
Kendler KS, Prescott CA: Caffeine intake, tolerance, and withdrawal in women: a population-based twin study. Am J Psychiatry 156(2):223–228, 1999
[PubMed]
 
Kendler KS, Myers JO, Gardner C: Caffeine intake, toxicity and dependence and lifetime risk for psychiatric and substance use disorders: an epidemiologic and co-twin control analysis. Psychol Med 36(12):1717–1725, 2006
[PubMed]
 
Strain EC, Mumford GK, Silverman K, Griffiths RR: Caffeine dependence syndrome: evidence from case histories and experimental evaluations. JAMA 272(13):1043–1048, 1994
[PubMed]
 
Alt RS, Morrissey RP, Gang MA, et al: Severe myeloneuropathy from acute high-dose nitrous (N2O) abuse. J Emerg Med 41(4):378–380, 2010
[PubMed]
 
Balster RL: Neural basis of inhalant abuse. Drug Alcohol Depend 51(1–2):207–214, 1998
[PubMed]
 
Blanton A: Nitrous oxide abuse: dentistry's unique addiction. J Tenn Dent Assoc 86(4):30–31, 2006
[PubMed]
 
Cartner M, Sinnott M, Silburn P: Paralysis caused by “nagging.”Med J Aust 187(6):366–367, 2007
[PubMed]
 
Colfax G, Coates TJ, Husnik MJ, et al: Longitudinal patterns of methamphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of San Francisco men who have sex with men. J Urban Health 82(1, suppl 1):i62–i70, 2005
[PubMed]
 
Dagher A, Robbins TW: Personality, addiction, dopamine: insights from Parkinson’s disease. Neuron 61(4):502–510, 2009
[PubMed]
 
Gupta PC, Ray CS: Epidemiology of betel quid usage. Ann Acad Med Singapore 33(4, suppl):31–36, 2004
[PubMed]
 
Hidaka Y, Ichikawa S, Koyano J, et al: Substance use and sexual behaviours of Japanese men who have sex with men: a nationwide internet survey conducted in Japan. BMC Public Health 6(239), September 26, 2006
[PubMed] | [CrossRef]
 
Kanayama G, Brower KJ, Wood RI, et al: Anabolic-androgenic steroid dependence: an emerging disorder. Addiction 104(12):1966–1978, 2009
[PubMed]
 
Kelly JP: Cathinone derivatives: a review of their chemistry, pharmacology and toxicology. Drug Test Anal 3(7–8):439–453, 2011
[PubMed]
 
Lampinen TM, Mattheis K, Chan K, Hogg RS: Nitrite inhalant use among young gay and bisexual men in Vancouver during a period of increasing HIV incidence. BMC Public Health 7(35), March 15, 2007
[PubMed] | [CrossRef]
 
Marsh N, Marsh A: A short history of nitoglycerine and nitric oxide in pharmacology and physiology. Clin Exp Pharmacol Physiol 27(4):313–319, 2000
[PubMed]
 
Richardson PG: Peripheral neuropathy following nitrous oxide abuse. Emerg Med Australas 22(1):88–90, 2010
[PubMed]
 
Ridenour TA, Bray BC, Cottler LB: Reliability of use, abuse, and dependence of four types of inhalants in adolescents and young adults. Drug Alcohol Depend 91(1):40–49, 2007
[PubMed]
 
Sethi NK, Mullin P, Torgovnick J, Capasso G: Nitrous oxide “Whippit” abuse presenting with cobalamin responsive psychosis. J Med Toxicol 2(2):71–74, 2006
[PubMed]
 
Substance Abuse and Mental Health Services Administration, Office of Applied Studies: Inhalant use across the adolescent years. The NSDUH Report, March 13, 2008. Available at: http://www.samhsa.gov/data/2k8/inhalants/inhalants.htm. Accessed May 26, 2011.
 
Wu LT, Schlenger WE, Ringwalt CL: Use of nitrite inhalants (“poppers”) among American youth. J Adolesc Health 37(1):52–60, 2005
[PubMed]
 
Baker TB, Breslau N, Covey L, Shiffman S: DSM criteria for tobacco use disorder and tobacco withdrawal: a critique and proposed revisions for DSM-5. Addiction 107(2):263–275, 2012
[PubMed] | [CrossRef]
 
Centers for Disease Control and Prevention: Vital signs: current cigarette smoking among adults aged≥18 years—United States, 2005–2010. MMWR Morb Mortal Wkly Rep 60(35):1207–1211, 2011
[PubMed]
 
DiFranza JR: Hooked from the first cigarette. Sci Am 298(5):82–87, 2008
[PubMed]
 
Giovino GA: The tobacco epidemic in the United States. Am J Prev Med 33(6 suppl):S318–S326, 2007
[PubMed]
 
Grant BF, Hasin DS, Chou SP, et al: Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 61(11):1107–1115, 2004
[PubMed]
 
Hughes JR: The effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res 9(3):315–327, 2007
[PubMed]
 
Hughes JR, Keely J, Naud S: Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 99(1):29–38, 2004
[PubMed]
 
Hughes JR, Helzer JE, Lindberg SA: Prevalence of DSM/ICD-defined nicotine dependence. Drug Alcohol Depend 85(2):91–102, 2006
[PubMed]
 
Kroon LA: Drug interactions with smoking. Am J Health Syst Pharm 64(18):1917–1921, 2007
[PubMed]
 
Mickens L, Ameringer K, Brightman M, Leventhal AM: Epidemiology, determinants, and consequences of cigarette smoking in African American women: an integrative review. Addict Behav 35(5):383–391, 2010
[PubMed]
 
Munafò M, Clark T, Johnstone E, et al: The genetic basis for smoking behavior: a systematic review and meta-analysis. Nicotine Tob Res 6(4):583–597, 2004
[PubMed]
 
National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health: The Health Consequences of Smoking. A Report of the Surgeon General.Atlanta, GA, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, May 27, 2004. Available at: http://www.cdc.gov/tobacco/data_statistics/sgr/2004/complete_report/index.htm. Accessed September 2012.
 
Piper ME, McCarthy DE, Baker TB: Assessing tobacco dependence: a guide to measure evaluation and selection. Nicotine Tob Res 8(3):339–351, 2006
[PubMed]
 
Shields P: Long-term nicotine replacement therapy: cancer risk in context. Cancer Prev Res 4(11):1719–1723, 2011
[PubMed]
 
Shiffman S, Hughes JR, Pillitteri JL, Burton SL: Persistent use of nicotine replacement therapy: an analysis of actual purchase patterns in a population-based sample. Tob Control 12(3):310–316, 2003
[PubMed]
 
Shmulewitz D, Keyes KM, Wall MM, et al: Nicotine dependence, abuse and craving: dimensionality in an Israeli sample. Addiction 106(9):1675–1686, 2011
[PubMed] | [CrossRef]
 
SRNT Subcommittee on Biochemical Verification: Biochemical verification of tobacco use and cessation. Nicotine Tob Res 4(2):149–159, 2002
[PubMed]
 
Wipfli H, Samet J: Global economic and health benefits of tobacco control, part 1. Clin Pharmacol Ther 86(3):263–271, 2009
[PubMed]
 
World Health Organization: WHO Report on the Global Tobacco Epidemic, 2008: The MPOWER Package. Geneva, World Health Organization, 2008
 
Ziedonis D, Hitsman B, Beckham JC, et al: Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob Res 10(12):1691–1715, 2008
[PubMed]
 
Aan Het Rot M, Zarate CAJr, Charney DS, Mathew SJ: Ketamine for depression: where do we go from here?Biol Psychiatry 72(7):537–547, 2012
[PubMed]
 
Baldridge EB, Bessen HA: Phencyclidine. Emerg Med Clin North Am 8(3):541–550, 1990
[PubMed]
 
Hanson GR, Venturelli PJ, Fleckenstein AE: Drugs and Society, 11th Edition. Burlington, MA, Jones & Bartlett Learning, 2012, pp 368–371
 
Johnston LD, O’Malley PM, Bachman JG, Schulenberger JE: Monitoring the Future national results on adolescent drug use: overview of key findings, 2011. Ann Arbor, Institute for Social Research, The University of Michigan, 2012
 
Luscher C: Drugs of abuse, in Basic and Clinical Pharmacology, 11th Edition. Edited by Katzung BG, Masters SB, Trevor AJ. Chicago, IL, McGraw-Hill Medical, 2009, pp 553–558
 
Martin PR: Substance-related disorders, in Current Diagnosis and Treatment: Psychiatry, 2nd Edition. Edited by Ebert MH, Loosen PT, Nurcombe B, Leckman JF. New York, McGraw-Hill Medical, 2008, pp 230–260
 
O’Brien CP: Drug addiction, in Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 12th Edition. Edited by Brunton L, Chabner B, Knollman B. New York, McGraw-Hill Professional, 2011, pp 649–668
 
Substance Abuse and Mental Health Services Administration, Office of Applied Studies: Characteristics of primary phencyclidine (PCP) admissions, 2001. The DASIS Report, May 7, 2004
 
Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality: National Survey on Drug Use and Health (NSDUH) series. 2009 and 2010. Available at: http://www.icpsr.umich.edu/icpsrweb/SAMHDA/series/64. Accessed September 20, 2012.
 
Thombs DL: A review of PCP abuse trends and perceptions. Public Health Rep 104(4):325–328, 1989
[PubMed]
 
Wu LT, Schlenger WE, Galvin DM: Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths. Drug Alcohol Depend 84(1):102–113, 2006
[PubMed]
 
Sannibale C, Fucito L, O’Connor D, Curry K: Process evaluation of an out-patient detoxification service. Drug Alcohol Rev 24(6):475–481, 2005
[PubMed]
 
Schuckit MA: Alcohol-use disorders. Lancet 373(9662):492–501, 2009
[PubMed]
 
Blanco C, Harford TC, Nunes E, et al: The latent structure of marijuana and cocaine use disorders: results from the National Longitudinal Alcohol Epidemiologic Survey (NLAES). Drug Alcohol Depend 91(1):91–96. 2007
[PubMed]
 
Chang A, Osterloh J, Thomas J: Levamisole: a dangerous new cocaine adulterant. Clin Pharmacol Ther 88(3):408–411, 2010
[PubMed]
 
Cruickshank CC, Dyer KR: A review of the clinical pharmacology of methamphetamine. Addiction 104(7):1085–1099, 2009
[PubMed]
 
Darke S, Kaye S, McKetin R, Duflou J: Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev 27(3):253–262, 2008
[PubMed]
 
Delaney-Black V, Chiodo LM, Hannigan JH, et al: Prenatal and postnatal cocaine exposure predict teen cocaine use. Neurotoxicol Teratol 33(1):110–119, 2011
[PubMed]
 
Hendrickson RG, Cloutier R, McConnell KJ: Methamphetamine-related emergency department utilization and cost. Acad Emerg Med 15(1):23–31, 2008
[PubMed]
 
Hser YI, Evans E, Huang D, et al: Comparing the dynamic course of heroin, cocaine, and methamphetamine use over 10 years. Addict Behav 33(12):1581–1589, 2008
[PubMed]
 
Khalsa ME, Tashkin DP, Perrochet B: Smoked cocaine: patterns of use and pulmonary consequences. J Psychoactive Drugs 24(3):265–272, 1992
[PubMed]
 
Lange RA, Hillis LD: Cardiovascular complications of cocaine use. N Engl J Med 345(5):351–358, 2001
[PubMed]
 
Levin KH, Herning RI, Better WE, et al: EEG absolute power during extended cocaine abstinence. J Addict Med 1(3):139–144, 2007
[PubMed]
 
Marinetti LJ: Observations regarding levamisole in the cocaine supply. Ann Intern Med, Jan 292009
 
McGregor C, Srisurapanont M, Jittiwutikarn J, et al: The nature, time course and severity of methamphetamine withdrawal. Addiction 100(9):1320–1329, 2005
[PubMed]
 
Mooney LJ, Glasner-Edwards S, Marinelli-Casey P, et al: Health conditions in methamphetamine-dependent adults 3 years after treatment. J Addict Med 3(3):155–163, 2009
[PubMed]
 
Newton TF, Kalechstein AD, Duran S, et al: Methamphetamine abstinence syndrome: preliminary findings. Am J Addict 13(3):248–255, 2004
[PubMed]
 
Poling J, Kosten TR, Sofuoglu M: Treatment outcome predictors for cocaine dependence. Am J Drug Alcohol Abuse 33(2):191–206, 2007
[PubMed]
 
Ren S, Tong W, Lai A, et al: Effect of long-term cocaine use on regional left ventricular function as determined by magnetic resonance imaging. Am J Cardiol 97(7):1085–1088, 2006
[PubMed]
 
RussellK, Dryden DM, Liang Y, et al: Risk factors for methamphetamine use in youth: a systematic review. BMC Pediatr 8:48, 2008
 
Schmidt L, Room R: Cross-cultural applicability in international classifications and research on alcohol dependence. J Stud Alcohol 60(4):448–462, 1999
[PubMed]
 
Schwartz BG, Rezkalla S, Kloner RA: Cardiovascular effects of cocaine. Circulation 122(24):2558–2569, 2010
[PubMed]
 
Scott JC, Woods SP, Matt GE, et al: Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev 17(3):275–297, 2007
[PubMed]
 
Shetty VS, Mooney LJ, Zigler CM, et al: The relationship between methamphetamine use and increased dental disease. J Am Dent Assoc 141(3):307–318, 2010
[PubMed]
 
Substance Abuse and Mental Health Services Administration, Office of Applied Studies: Primary methamphetamine/amphetamine admissions to substance abuse treatment: 2005. The DASIS Report. Rockville, MD, Substance Abuse and Mental Health Services Administration, February 7, 2008. Available at: http://www.samhsa.gov/data/2k8/methamphetamineTX/meth.htm. Accessed September 2012.
 
Substance Abuse and Mental Health Services Administration, Office of Applied Studies: Trends in methamphetamine admissions to treatment: 1997–2007. The TEDS Report.Rockville, MD, Substance Abuse and Mental Health Services Administration, October 1, 2009. Available at: http://www.samhsa.gov/data/2k9/209/209MethTrends2k9_web.pdf. Accessed September 2012.
 
Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality: Results from the 2010 National Survey on Drug Use and Health: summary of national findings. NSDUH Series H-41, HHS Publ No SMA 11-4658. Rockville, MD, Substance Abuse and Mental Health Services Administration, September 2011. Available at: http://www.samhsa.gov/data/nsduh/2k10nsduh/2k10results.htm. Accessed September 2012.
 
Wang GJ, Volkow ND, Chang L, et al: Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. Am J Psychiatry 161(2):242–248, 2004
[PubMed]
 
Wilens TE, Adler LA, Adams J, et al: Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry 47(1):21–31, 2008
[PubMed]
 
Wu LT, Pan JJ, Blazer DG, et al: The construct and measurement equivalence of cocaine and opioid dependences: a National Drug Abuse Treatment Clinical Trials Network (CTN) study. Drug Alcohol Depend 103(3):114–123. 2009
[PubMed]
 
Wu LT, Pan JJ, Blazer DG, et al: Using a latent variable approach to inform gender and racial/ethnic differences in cocaine dependence: a National Drug Abuse Treatment Clinical Trials Network study. J Subst Abuse Treat 38(suppl 1):S70–S79, 2010
[PubMed]
 
Agrawal A, Lynskey MT: Candidate genes for cannabis use disorders: findings, challenges and directions. Addiction 104(4):518–532, 2009
[PubMed]
 
Anthony JC: The epidemiology of cannabis dependence, in Cannabis Dependence: Its Nature, Consequences and Treatment. Edited by Roffman RA, Stephens RS. Cambridge, UK, Cambridge University Press, 2006, pp 58–95
 
Budney AJ: Are specific dependence criteria necessary for different substances: how can research on cannabis inform this issue?Addiction 101(suppl 1):125–133, 2006
[PubMed]
 
Budney AJ, Hughes JR, Moore BA, Vandrey R: Review of the validity and significance of the cannabis withdrawal syndrome. Am J Psychiatry 161(11):1967–1977, 2004
[PubMed]
 
Budney AJ, Vandrey RG, Hughes JR, et al: Comparison of cannabis and tobacco withdrawal: severity and contribution to relapse. J Subst Abuse Treat 35(4):362–368, 2008
[PubMed]
 
Budney A, Vandrey R, Fearer SA: Cannabis (marijuana), in Lowenson and Ruiz’s Substance Abuse: A Comprehensive Textbook, 5th Edition. Edited by Ruiz P, Strain E. Baltimore, MD, Lippincott Williams & Wilkins, 2011, pp 214–237
 
Compton WM, Grant BF, Colliver JD, et al: Prevalence of marijuana use disorders in the United States: 1991–1992 and 2001–2002. JAMA 291(17):2114–2121, 2004
[PubMed]
 
de Graaf R, Radovanovic M, van Laar M, et al: Early cannabis use and estimated risk of later onset of depression spells: epidemiologic evidence from the population-based World Health Organization World Mental Health Survey Initiative. Am J Epidemiol 172(2):149–159, 2010
[PubMed]
 
Degenhardt L, Chiu WT, Sampson N, et al: Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med 5(7):e141, 2008
[PubMed]
 
Degenhardt L, Dierker L, Chiu WT, et al: Evaluating the drug use “gateway” theory using cross-national data: consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys. Drug Alcohol Depend 108(1–2):84–97, 2010
[PubMed]
 
Fergusson DM, Boden JM, Horwood LJ: Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction 101(4):556–569, 2006
[PubMed]
 
Grant I, Gonzalez R, Carey CL, et al: Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study. J Int Neuropsychol Soc 9(5):679–689, 2003
[PubMed]
 
Hall W, Degenhardt L: Prevalence and correlates of cannabis use in developed and developing countries. Curr Opin Psychiatry 20(4):393–397, 2007
[PubMed]
 
Iacono WG, Malone SM, McGue M: Behavioral disinhibition and the development of early-onset addiction: common and specific influences. Annu Rev Clin Psychol 4:325–348, 2008
[PubMed]
 
Levin KH, Copersino ML, Heishman SJ, et al: Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers. Drug Alcohol Depend 111(1–2):120–127, 2010
[PubMed]
 
Lichtman AH, Martin BR: Cannabinoid tolerance and dependence, in Handbook of Experimental Pharmacology: Cannabinoids. Edited by Pertwee RG. Berlin, Springer-Verlag, 2005, pp 691–717
 
Lynskey MT, Hall W: The effects of adolescent cannabis use on educational attainment: a review. Addiction 95(11):1621–1630, 2000
[PubMed]
 
Lynskey MT, Heath AC, Bucholz KK, et al: Escalation of drug use in early-onset cannabis users vs co-twin controls. JAMA 289(4):427–433, 2003
[PubMed]
 
Mehmedic Z, Chandra S, Slade D, et al: Potency trends of delta9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008. J Forensic Sci 55(5):1209–1217, 2010
[PubMed] | [CrossRef]
 
Roffman R, Stephens R (eds): Cannabis Dependence: Its Nature, Consequences, and Treatment. Cambridge, UK, Cambridge University Press, 2006
 
Seely KA, Prather PL, James LP, Moran JH: Marijuana-based drugs: innovative therapeutics or designer drugs of abuse?Mol Interv 11(1):36–51, 2011
[PubMed]
 
Stinson FS, Ruan WJ, Pickering R, Grant BF: Cannabis use disorders in the USA: prevalence, correlates and co-morbidity. Psychol Med 36(10):1447–1460, 2006
[PubMed]
 
Tanda G, Goldberg SR: Cannabinoids: reward, dependence, and underlying neurochemical mechanisms—a review of recent preclinical data. Psychopharmacology (Berl) 169(2):115–134, 2003
[PubMed]
 
Tashkin DP, Baldwin GC, Sarafian T, et al: Respiratory and immunologic consequences of marijuana smoking. J Clin Pharmacol 42(11 suppl):71S–81S, 2002
[PubMed]
 
Vandrey R, Mintzer MZ: Performance and cognitive alterations, in The Pharmacology and Treatment of Substance Abuse: An Evidence-Based Approach. Edited by Cohen L, Collins FL, Young AM, et al. Mahwah, NJ, Erlbaum, 2009, pp 41–62
 
Dawson DA, Goldstein RB, Chou SP, et al: Age at first drink and the first incidence of adult-onset DSM-IV alcohol use disorders. Alcohol Clin Exp Res 32(12):2149–2160, 2008
[PubMed]
 
Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE: Monitoring the Future: National Survey Results on Drug Use, 1975–2008:Volume 1: Secondary School Students. NIH Publ No 09-7402. Bethesda, MD, National Institute on Drug Abuse, 2009
 
Nelson EC, Heath AC, Bucholz KK, et al: Genetic epidemiology of alcohol-induced blackouts. Arch Gen Psychiatry 61(3):257–263, 2004
[PubMed]
 
Alegria AA, Petry NM, Hasin DS, et al: Disordered gambling among racial and ethnic groups in the US: results from the national epidemiologic survey on alcohol and related conditions. CNS Spectr 14(3):132–142, 2009
[PubMed]
 
Barnes GM, Welte JW, Hoffman JH, Tidwell MC: Comparisons of gambling and alcohol use among college students and noncollege young people in the United States. J Am Coll Health 58(5):443–452, 2010
[PubMed]
 
Blanco C, Hasin DS, Petry N, et al: Sex differences in subclinical and DSM-IV pathological gambling: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med 36(7):943–953, 2006
[PubMed]
 
Burge AN, Pietrzak RH, Petry NM: Pre/early adolescent onset of gambling and psychosocial problems in treatment-seeking pathological gamblers. J Gambl Stud 22(3):263–274, 2006
[PubMed]
 
Currie SR, Hodgins DC, Wang J, et al: Risk of harm among gamblers in the general population as a function of level of participation in gambling activities. Addiction 101(4):570–580, 2006
[PubMed]
 
Eisen SA, Lin N, Lyons MJ, et al: Familial influences on gambling behavior: an analysis of 3359 twin pairs. Addiction 93(9):1375–1384, 1998
[PubMed]
 
Gerstein D, Hoffmann J, Larison C, et al: Gambling Impact and Behavior Study: Report to the National Gambling Impact Study Commission. Chicago, IL, National Opinion Research Center, University of Chicago, 1999
 
Hodgins DC, el-Guebaly N: Natural and treatment-assisted recovery from gambling problems: a comparison of resolved and active gamblers. Addiction 95(5):777–789, 2000
[PubMed]
 
Kessler RC, Hwang I, LaBrie R, et al: DSM-IV pathological gambling in the National Comorbidity Survey Replication. Psychol Med 38(9):1351–1360, 2008
[PubMed]
 
Langhinrichsen-Rohling J, Rohde P, Seeley JR, Rohling ML: Individual, family, and peer correlates of adolescent gambling. J Gambl Stud 20(1):23–46, 2004
[PubMed]
 
Ledgerwood DM, Petry NM: Subtyping pathological gamblers based on impulsivity, depression, and anxiety. Psychol Addict Behav 24(4):680–688, 2010
[PubMed]
 
Morasco BJ, Petry NM: Gambling problems and health functioning in individuals receiving disability. Disabil Rehabil 28(10):619–623, 2006
[PubMed]
 
Morasco BJ, Pietrzak RH, Blanco C, et al: Health problems and medical utilization associated with gambling disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychosom Med 68(6):976–984, 2006
[PubMed]
 
Petry NM: A comparison of treatment-seeking pathological gamblers based on preferred gambling activity. Addiction 98(5):645–655, 2003
[PubMed]
 
Petry NM, Kiluk BD: Suicidal ideation and suicide attempts in treatment-seeking pathological gamblers. J Nerv Ment Dis 190(7):462–469, 2002
[PubMed]
 
Petry NM, Stinson FS, Grant BF: Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 66(5):564–574, 2005
[PubMed]
 
Petry NM, Ammerman Y, Bohl J, et al: Cognitive-behavioral therapy for pathological gamblers. J Consult Clin Psychol 74(3):555–567, 2006
[PubMed]
 
Potenza MN, Xian H, Shah K, et al: Shared genetic contributions to pathological gambling and major depression in men. Arch Gen Psychiatry 62(9):1015–1021, 2005
[PubMed]
 
Slutske WS: Natural recovery and treatment-seeking in pathological gambling: results of two U.S. national surveys. Am J Psychiatry 163(2):297–302, 2006
[PubMed]
 
Slutske WS, Eisen S, True WR, et al: Common genetic vulnerability for pathological gambling and alcohol dependence in men. Arch Gen Psychiatry 57(7):666–673, 2000
[PubMed]
 
Slutske WS, Eisen S, Xian H, et al: A twin study of the association between pathological gambling and antisocial personality disorder. J Abnorm Psychol 110(2):297–308, 2001
[PubMed]
 
Slutske WS, Jackson KM, Sher KJ: The natural history of problem gambling from age 18 to 29. J Abnorm Psychol 112(2):263–274, 2003
[PubMed]
 
Slutske WS, Caspi A, Moffitt TE, Poulton R: Personality and problem gambling: a prospective study of a birth cohort of young adults. Arch Gen Psychiatry 62(7):769–775, 2005
[PubMed]
 
Slutske WS, Piasecki TM, Blaszczynski A, Martin NG: Pathological gambling recovery in the absence of abstinence. Addiction 105(12):2169–2175, 2010
[PubMed] | [CrossRef]
 
Tavares H, Martins SS, Lobo DS, et al: Factors at play in faster progression for female pathological gamblers: an exploratory analysis. J Clin Psychiatry 64(4):433–438, 2003
[PubMed]
 
Volberg RA, Abbott MW: Gambling and problem gambling among indigenous peoples. Subst Use Misuse 32(11):1525–1538, 1997
[PubMed]
 
Walker M, Toneatto T, Potenza MN, et al: A framework for reporting outcomes in problem gambling treatment research: the Banff, Alberta Consensus. Addiction 101(4):504–511, 2006
[PubMed]
 
Wardman D, el-Guebaly N, Hodgins D: Problem and pathological gambling in North American Aboriginal populations: a review of the empirical literature. J Gambl Stud 17(2):81–100, 2001
[PubMed]
 
Welte J, Barnes G, Wieczorek W, et al: Alcohol and gambling pathology among U.S. adults: prevalence, demographic patterns and comorbidity. J Stud Alcohol 62(5):706–712, 2001
[PubMed]
 
Xian H, Shah KR, Phillips SM, et al: Association of cognitive distortions with problem and pathological gambling in adult male twins. Psychiatry Res 160(3):300–307, 2008
[PubMed]
 
Becker WC, Fiellin DA, Desai RA: Non-medical use, abuse and dependence on sedatives and tranquilizers among U.S. adults: psychiatric and socio-demographic correlates. Drug Alcohol Depend 90(2–3):280–287, 2007
[PubMed]
 
Compton WM, Conway KP, Stinson FS, et al: Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific substance use disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 66(6):677–685, 2005
[PubMed]
 
Compton WM, Thomas YF, Stinson FS, Grant BF: Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 64(5):566–576, 2007
[PubMed]
 
Conway KP, Compton WM, Stinson FS, Grant BF: Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 67(2):247–257, 2006
[PubMed]
 
Gillespie NA, Neale MC, Prescott CA, et al: Factor and item-response analysis DSM-IV criteria for abuse of and dependence on cannabis, cocaine, hallucinogens, sedatives, stimulants and opioids. Addiction 102(6):920–930, 2007
[PubMed]
 
Iguchi MY, Handelsman L, Bickel WK, Griffiths RR: Benzodiazepine and sedative use/abuse by methadone maintenance clients. Drug Alcohol Depend 32(3):257–266, 1993
[PubMed]
 
Kendler KS, Jacobson KC, Prescott CA, Neale MC: Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry 160(4)687–695, 2003
[PubMed]
 
Licata SC, Rowlett JK: Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond. Pharmacol Biochem Behav 90(1):74–89, 2008
[PubMed]
 
McCabe SE, West BT, Morales M, et al: Does early onset of non-medical use of prescription drugs predict subsequent prescription drug abuse and dependence? Results from a national study. Addiction 102(12):1920–1930, 2007
[PubMed]
 
McCabe SE, Cranford JA, West BT: Trends in prescription drug abuse and dependence: co-occurrence with other substance use disorders, and treatment utilization: results from two national surveys. Addict Behav 33(10):1297–1305, 2008
[PubMed]
 
O’Brien CP: Benzodiazepine use, abuse, and dependence. J Clin Psychiatry 66(suppl 2):28–33, 2005
[PubMed]
 
Substance Abuse and Mental Health Services Administration: Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-41, HHS Publ No (SMA) 11-4658. Rockville, MD, Substance Abuse and Mental Health Services Administration, 2011. Available at: http://www.samhsa.gov/data/nsduh/2k10nsduh/2k10results.htm.
 
Tsuang MT, Lyons MJ, Meyer JM, et al: Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry 55(11):967–972, 1998
[PubMed]
 
Compton WM, Conway KP, Stinson FS, et al: Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific substance use disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 66(6):677–685, 2005
[PubMed]
 
Compton WM, Thomas YF, Stinson FS, Grant BF: Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 64(5):566–576, 2007
[PubMed]
 
Compton WM, Dawson D, Duffy SQ, Grant BF: The effect of inmate populations on estimates of DSM-IV alcohol and drug use disorders in the United States. Am J Psychiatry 167(4):473–475, 2010
[PubMed]
 
Conway KP, Compton WM, Stinson FS, Grant BF: Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 67(2):247–257, 2006
[PubMed]
 
European Monitoring Centre for Drugs and Drug Addiction: Opioid use and drug injection, in Annual Report 2010: The States of the Drugs Problem in Europe. Lisbon, European Monitoring Centre for Drugs and Drug Addiction, November 2010. Available at: http://www.emcdda.europa.eu/online/annual-report/2010/opioids. Accessed April 15, 2012.
 
Fatseas M, Denis C, Massida Z, et al: Cue-induced reactivity, cortisol response and substance use outcome in treated heroin dependent individuals. Biol Psychiatry 70(8):720–727, 2011a
[PubMed]
 
Fatseas M, Denis C, Serre F, et al: Change in HIV-HCV risk-taking behavior and seroprevalence among opiate users seeking treatment over an 11-year period and harm reduction policy. AIDS Behav 16(7):2082–2090, 2011b
[PubMed]
 
Hser YI, Huang D, Chou CP, Anglin MD: Trajectories of heroin addiction: growth mixture modeling results based on a 33-year follow-up study. Eval Rev 31(6):548–563, 2007
[PubMed]
 
Kendler KS, Jacobson KC, Prescott CA, Neale MC: Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry 160(4):687–695, 2003
[PubMed]
 
Price RK, Risk NK, Spitznagel EL: Remission from drug abuse over a 25-year period: patterns of remission and treatment use. Am J Public Health 91(7):1107–1113, 2001
[PubMed]
 
Price RK, Risk NK, Haden AH, et al: Post-traumatic stress disorder, drug dependence, and suicidality among male Vietnam veterans with a history of heavy drug use. Drug Alcohol Depend 76(suppl):S31–43, 2004
[PubMed]
 
Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality: 2010 National Survey on Drug Use and Health:Table 5.2B Substance dependence or abuse for specific substances in the past year, by age group: percentages 2009–2010. Rockville, MD, Substance Abuse and Mental Health Services Administration, 2011. Available at: http:oas.samhsa.gov/nsduh/2K10NSDUH/tabs/Sect5peTabs1to56.htm#tab5.2B. Accessed June 15, 2012.
 
Tsuang MT, Lyons MJ, Meyer JM, et al: Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry 55(11):967–972, 1998
[PubMed]
 
Wu LT, Pan JJ, Blazer DG, et al: The construct and measurement equivalence of cocaine and opioid dependences: a National Drug Abuse Treatment Clinical Trials Network (CTN) study. Drug Alcohol Depend 103(3):114–123, 2009
[PubMed]
 
Botnick MR, Heath KV, Cornelisse PG, et al: Correlates of suicide attempts in an open cohort of young men who have sex with men. Can J Public Health 93(1):59–62, 2002
[PubMed]
 
Cairney S, Dingwall K: The mysterious practice of petrol sniffing in isolated indigenous communities. J Paediatr Child Health 46(9):510–515, 2010
[PubMed] | [CrossRef]
 
Compton WM, Conway KP, Stinson FS, et al: Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 66(6):677–685, 2005
[PubMed]
 
Han B, Gfroerer JC, Colliver JD: Associations between duration of illicit drug use and health conditions: results from the 2005–2007 national surveys on drug use and health. Ann Epidemiol 20(4):289–297, 2010
[PubMed]
 
Howard MO, Perron BE, Sacco P, et al: Suicide ideation and attempts among inhalant users: results from the national epidemiologic survey on alcohol and related conditions. Suicide Life Threat Behav 40(3):276–286, 2010
[PubMed]
 
Iacono WG, Malone SM, McGue M: Behavioral disinhibition and the development of early-onset addiction: common and specific influences. Ann Rev Clin Psychol 4:325–348, 2008
[PubMed]
 
Marsolek MR, White NC, Litovitz TL: Inhalant abuse: monitoring trends by using poison control data. Pediatrics 125(5):906–913, 2010
[PubMed]
 
Mitchell CM, Beals J, Novins DK, et al: Drug use among two American Indian populations: prevalence of lifetime use and DSM-IV substance use disorders. Drug Alcohol Depend 69(1):29–41, 2003
[PubMed]
 
Miyata H, Kono J, Ushijima S, et al: Clinical features of nicotine dependence compared with those of alcohol, methamphetamine, and inhalant dependence. Ann N Y Acad Sci 1025:481–488, 2004
[PubMed]
 
Perron BE, Howard MO: Adolescent inhalant use, abuse and dependence. Addiction 104(7):1185–1192, 2009
[PubMed]
 
Perron B, Howard MO, Maitra S, Vaughn MG: Prevalence, timing, and predictors of transitions from inhalant use to inhalant use disorders. Drug Alcohol Depend 100(3):277–284, 2009
[PubMed]
 
Pfeiffer H, Al Khaddam M, Brinkmann B, et al: Sudden death after isobutane sniffing: a report of two forensic cases. Int J Legal Med 120(3):168–173, 2006
[PubMed]
 
Ridenour TA, Bray BC, Cottler LB: Reliability of use, abuse, and dependence of four types of inhalants in adolescents and young adults. Drug Alcohol Depend 91(1):40–49, 2007
[PubMed]
 
Sakai JT, Crowley TJ: Inhalant-related disorders, in Comprehensive Textbook of Psychiatry, 9th Edition, Vol 1. Edited by Sadock BJ, Sadock VA, Ruiz P. Baltimore, MD, Williams & Wilkins, 2009, pp 1341–1352
 
Seth R, Kotwal A, Ganguly KK: Street and working children of Delhi, India, misusing toluene: an ethnographic exploration. Subst Use Misuse 40(11):1659–1679, 2005
[PubMed]
 
Substance Abuse and Mental Health Services Administration, Office of Applied Studies: Inhalant use across the adolescent years. The NSDUH Report, March 13, 2008. Available at: http://www.samhsa.gov/data/2k8/inhalants/inhalants.htm. Accessed June 15, 2012.
 
Substance Abuse and Mental Health Services Administration, Office of Applied Studies: Table 9 in Prevalence of Substance Use Disorders by Sex and Race-Ethnicity (12–17 year olds): 2009 National Survey on Drug Use and Health. Rockville, MD, Substance Abuse and Mental Health Services Administration, 2010
 
Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality: 2010 National Survey on Drug Use and Health: Table 5.2B Substance dependence or abuse for specific substances in the past year, by age group: percentages 2009–2010. Rockville, MD, Substance Abuse and Mental Health Services Administration, 2011. Available at: http:oas.samhsa.gov/nsduh/2K10NSDUH/tabs/Sect5peTabs1to56.htm#tab5.2B. Accessed June 15, 2012.
 
Wu LT, Pilowsky DJ, Schlenger WE: Inhalant abuse and dependence among adolescents in the United States. J Am Acad Child Adolesc Psychiatry 43(10):1206–1214, 2004
[PubMed]
 
Wu LT, Howard MO, Pilowsky DJ: Substance use disorders among inhalant users: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Addict Behav 33(7):968–973, 2008
[PubMed]
 
Chung T, Martin CS: Classification and short-term course of DSM-IV cannabis, hallucinogen, cocaine, and opioid disorders in treated adolescents. J Consult Clin Psychol 73(6):995–1004, 2005
[PubMed]
 
Compton WM, Conway KP, Stinson FS, et al: Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 66(6):677–685, 2005
[PubMed]
 
Compton WM, Thomas YF, Stinson FS, Grant BF: Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 64(5):566–576, 2007
[PubMed]
 
Cottler LB, Womack SB, Compton WM, Ben-Abdallah A: Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria. Hum Psychopharmacol 16(8):599–606, 2001
[PubMed]
 
Cottler LB, Leung KS, Abdallah AB: Test-re-test reliability of DSM-IV adopted criteria for 3,4-methylenedioxymethamphetamine (MDMA) abuse and dependence: a cross-national study. Addiction 104(10):1670–1690, 2009
[PubMed]
 
El-Mallakh RS, Halpern JH, Abraham HD: Substance abuse: hallucinogen- and MDMA-related disorders, in Psychiatry, 3rd Edition. Edited by Tasman A, Kay J, Lieberman JA, et al. London, Wiley, 2008, pp 1100–1126
 
Gouzoulis-Mayfrank E, Daumann J: Neurotoxicity of drugs of abuse—the case of methylenedioxyamphetamines (MDMA, ecstasy) and amphetamines. Dialogues Clin Neurosci 11(3):305–317, 2009
[PubMed]
 
Halpern JH: Hallucinogens: an update. Curr Psychiatry Rep 5(5):347–354, 2003
[PubMed]
 
Halpern JH, Sherwood AR, Hudson JI, et al: Psychological and cognitive effects of long-term peyote use among Native Americans. Biol Psychiatry 58(8):624–631, 2005
[PubMed]
 
Kendler KS, Karkowski LM, Neale MC, Prescott CA: Illicit psychoactive substance use, heavy use, abuse and dependence in a US population-based sample of male twins. Arch Gen Psychiatry 57(3):261–269, 2000
[PubMed]
 
Kerridge BT, Saha TD, Smith S, et al: Dimensionality of hallucinogen and inhalant/solvent abuse and dependence criteria: implications for the Diagnostic and Statistical Manual of Mental Disorders—Fifth Edition. Addict Behav 36(9):912–918, 2011
[PubMed] | [CrossRef]
 
Martins SS, Storr CL, Alexandre PK, Chilcoat HD: Adolescent ecstasy and other drug use in the National Survey of Parents and Youth: the role of sensation-seeking, parental monitoring and peer’s drug use. Addict Behav 33(7):919–933, 2008
[PubMed]
 
Passie T, Halpern JH, Stichtenoth DO, et al: The pharmacology of lysergic acid diethylamide: a review. CNS Neurosci Ther 14(4):295–314, 2008
[PubMed]
 
Perron BE, Ahmedani BK, Vaughn MG, et al: Use of Salvia divinorum in a nationally representative sample. Am J Drug Alcohol Abuse 38(1):108–113, 2012
[PubMed] | [CrossRef]
 
Salomon RM, Karageorgiou J, Dietrich MS, et al: MDMA (Ecstasy) association with impaired fMRI BOLD thalamic coherence and functional connectivity. Drug Alcohol Depend 120(1–3):41–47, 2011
[PubMed] | [CrossRef]
 
Substance Abuse and Mental Health Services Administration: Results From the 2010 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-41, HHS Publication No (SMA) 11-4658. Rockville, MD, Substance Abuse and Mental Health Services Administration, September 2011. Available at: http://www.samhsa.gov/data/NSDUH/2k10Results/Web/HTML/2k10Results.htm. Accessed March 20, 2012.
 
Tsuang MT, Lyons MJ, Meyer JM, et al: Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry 55(11):967–972, 1998
[PubMed]
 
Wu LT, Ringwalt CL, Mannelli P, Patkar AA: Hallucinogen use disorders among adult users of MDMA and other hallucinogens. Am J Addict17(5):354–363, 2008
[PubMed]
 
Wu LT, Parrott AC, Ringwalt CL, et al: The high prevalence of substance use disorders among recent MDMA users compared with other drug users: implications for intervention. Addict Behav 34(8):654–661, 2009a
[PubMed]
 
Wu LT, Ringwalt CL, Weiss RD, Blazer DG: Hallucinogen-related disorders in a national sample of adolescents: the influence of ecstasy/MDMA use. Drug Alcohol Dep 104(1–2):156–166, 2009b
[PubMed]
 
Wu LT, Parrott AC, Ringwalt CL, et al: The variety of ecstasy/MDMA users: results from the National Epidemiologic Survey on alcohol and related conditions. Am J Addict 18(6):452–461, 2009c
[PubMed]
 
Wu LT, Pan JJ, Yang C, et al: An item response theory analysis of DSM-IV criteria for hallucinogen abuse and dependence in adolescents. Addict Behav 35(3):273–277, 2010
[PubMed]
 
Wu P, Liu X, Fan B: Factors associated with initiation of ecstasy use among US adolescents: findings from a national survey. Drug Alcohol Depend 106(2–3):193–198, 2010
[PubMed]
 
Zimmermann P, Wittchen HU, Waszak F, et al: Pathways into ecstasy use: the role of prior cannabis use and ecstasy availability. Drug Alcohol Depend 79(3):331–341, 2005
[PubMed]
 
Borges G, Ye Y, Bond J, et al: The dimensionality of alcohol use disorders and alcohol consumption in a cross-national perspective. Addiction 105(2):240–254, 2010
[PubMed] | [CrossRef]
 
Conigrave KM, Degenhardt LJ, Whitfield JB, et al: CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. Alcohol Clin Exp Res 26(3):332–339, 2002
[PubMed]
 
Dick DM, Bierut L, Hinrichs A, et al: The role of GABRA2 in risk for conduct disorder and alcohol and drug dependence across developmental stages. Behav Genet 36(4):577–590, 2006
[PubMed] | [CrossRef]
 
Eng MY, Luczak SE, Wall TL: ALDH2, ADH1B, and ADH1C genotypes in Asians: a literature review. Alcohol Res Health 30(1):22–27, 2007
[PubMed]
 
Gossop M, Moos R: Substance misuse among older adults: a neglected but treatable problem. Addiction 103(3):347–348, 2008
[PubMed] | [CrossRef]
 
Harford TC, Yi HY, Faden VB, Chen CM: The dimensionality of DSM-IV alcohol use disorders among adolescent and adult drinkers and symptom patterns by age, gender, and race/ethnicity. Alcohol Clin Exp Res 33(5):868–878, 2009
[PubMed] | [CrossRef]
 
Hill SY, Steinhauer SR, Locke-Wellman J, Ulrich R: Childhood risk factors for young adult substance dependence outcome in offspring from multiplex alcohol dependence families: a prospective study. Biol Psychiatry 66(8):750–757, 2009
[PubMed]
 
Hintzen AK, Cramer J, Karagülle D, et al: Does alcohol craving decrease with increasing age? Results from a cross-sectional study. J Stud Alcohol Drugs 72(1):158–162, 2011
[PubMed]
 
Moos RJ, Moos BS: Rates and predictors of relapse after natural and treated remission from alcohol use disorders. Addiction 101(2):212–222, 2006
[PubMed] | [CrossRef]
 
Niemelä O: Biomarkers in alcoholism. Clin Chim Acta 377(1–2):39–49, 2007
[PubMed] | [CrossRef]
 
Nurnberger JIJr, Bierut LJ: Seeking the connections:alcoholism and our genes. Sci Am 296(4):46–53, 2007
[PubMed]
 
Pleis JR, Ward BW, Lucas JW: Summary health statistics for U.S. adults: National Health Interview Survey, 2009. National Center for Health Statistics. Vital Health Stat 10 249:1–207, 2010, Tables 26 and 27
 
Rehm J, Mathers C, Popova S, et al: Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 373(9682):2223–2233, 2009
[PubMed] | [CrossRef]
 
Rumpf HJ, Bischof G, Hapke U, et al: Stability of remission from alcohol dependence without formal help. Alcohol Alcohol 41(3):311–314, 2006
[PubMed] | [CrossRef]
 
Saha TD, Stinson FS, Grant BF: The role of alcohol consumption in future classifications of alcohol use disorders. Drug Alcohol Depend 89(1):82–92, 2007
[PubMed] | [CrossRef]
 
Sartor CE, Lynskey MT, Bucholz KK, et al: Timing of first alcohol use and alcohol dependence: evidence of common genetic influences. Addiction 104(9):1512–1518, 2009
[PubMed] | [CrossRef]
 
Schuckit MA: Comorbidity between substance use disorders and psychiatric conditions. Addiction 101(suppl 1):76–88, 2006a
[PubMed] | [CrossRef]
 
Schuckit MA: Drug and Alcohol Abuse: A Clinical Guide to Diagnosis and Treatment, 6th Edition. New York, Springer, 2006b
 
Schuckit MA: Alcohol-use disorders. Lancet 373(9662):492–501, 2009a
[PubMed] | [CrossRef]
 
Schuckit MA: An overview of genetic influences in alcoholism. J Subst Abuse Treat 36(1):S5–14, 2009b
[PubMed]
 
Schuckit MA: Ethanol and methanol, in Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 12th Edition. Edited by Brunton L, Chabner B, Knollmann BC. New York, McGraw-Hill, 2011, pp 629–647
 
Schuckit MA: Alcohol and alcoholism, in Harrison’s Principles of Internal Medicine, 18th Edition. Edited by Fauci AS, Braunwald E, Kasper DL, et al. New York, McGraw-Hill, 2012, pp 3446–3552
 
Schuckit MA, Smith TL: Onset and course of alcoholism over 25 years in middle class men. Drug Alcohol Depend 113(1):21–28, 2011
[PubMed] | [CrossRef]
 
Schuckit MA, Smith TL, Heron J, et al: Testing a level of response to alcohol-based model of heavy drinking and alcohol problems in 1,905 17-year-olds. Alcohol Clin Exp Res 35(10):1897–1904, 2011
[PubMed] | [CrossRef]
 
Tan EC, Lim L, Leong JY, et al: Alcohol and aldehyde dehydrogenase polymorphisms in Chinese and Indian populations. Subst Use Misuse 45(1–2):1–14, 2010
[PubMed] | [CrossRef]
 
Trim RS, Schuckit MA, Smith TL: The relationships of the level of response to alcohol and additional characteristics to alcohol use disorders across adulthood: a discrete-time survival analysis. Alcohol Clin Exp Res 33(9):1562–1570, 2009
[PubMed] | [CrossRef]
 
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Related Content
Articles
Books
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 19.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 23.  >
Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 17.  >
The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 1.  >
Topic Collections
Psychiatric News
PubMed Articles
 
  • Print
  • PDF
  • E-mail
  • Chapter Alerts
  • Get Citation